Morie A. Gertz, MD, MACP | Authors

Case Presentation 2: Transplant-Ineligible NDMM and Treatment With the DRd Regimen

May 24, 2022

Experts review a second patient case wherein transplant-ineligible newly diagnosed multiple myeloma was treated with the daratumumab, lenalidomide and dexamethasone regimen and how updated data from the MAIA trial can be incorporated into clinical practice.